The aim of AVROBIO’s gene therapy programs is to deliver lasting and meaningful benefits for patients with rare genetic diseases.
Our focus is on serious rare diseases, where a faulty gene results in a lack of an essential enzyme or protein.
We are developing therapies using our gene therapy approach to transform a patient’s own cells into a drug product.
SIGN UP for our Press Releases
To receive our press releases, please click on the link to sign up. Thank you!